FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral NeuropathyPRNewsWire • 01/26/23
Abbott Laboratories Skids As Covid Testing Weighs On Organic GrowthInvestors Business Daily • 01/25/23
Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial OutlookPRNewsWire • 01/25/23